Search News Archives
Social Media
Will BRIC be the Savior for the Life Sciences and Medical Devices Sector? Seal of Approval for Pepceuticals ZEISS Lightsheet Z.1 awarded with Best New Life Science Product of 2012 IDT and SGI-DNA Broaden Their Collaboration to Provide Synthetic DNA Products up to 2 Mbp Watson-Marlow OEM pumps help push the boundaries of automated cell culture Breakthrough in non-invasive gut health testing New Portable SPECTROSCOUT XRF Analyzer - the Lab that Goes Anywhere ZEISS SIGMA used to analyze Russian meteorite that fell in Chelyabinsk region
Waters Updates Alliance HPLC Designs Without Impacting Established Validated Methods Porvair Sciences Expands Product Range for Epigenetics Thermo Fisher Scientific Introduces Gas Chromatography Headspace Autosampler for Organic Volatiles New Amicon® Pro Purification System for Protein Purification from Merck Millipore Wyatt Calypso Succeeds in ABRF-MIRG Study Revolutionize your pipetting with the new Biohit Picus electronic pipette Easy, Reliable Weighing in Regulated Areas Phenom proX all-in-one desktop SEM Flash of inspiration in the shaft tunnel - IKA launches the new video for UTTD control The only Chromatography Autosampler you will ever need! JG Finneran Associates introduces the 96-Well Multi-Tier Microtiter Plate System (Patented) IC for the people – Metrohm celebrates 25 years of ion chromatography
For further information or to sign up to receive any of our E-Newsletters click here Reading and Imaging are Combined in BioTek's Revolutionary, New Cytation™3 ZEISS SIGMA used to analyze Russian meteorite that fell in Chelyabinsk region New SPOT Insight™ Gigabit Camera Brings Microscopy Presentations to Life ZEISS Lightsheet Z.1 awarded with Best New Life Science Product of 2012 Malvern’s Dr E Neil Lewis takes his place among chemical imaging pioneers Waters Biopharmaceutical, Bioanalysis and Screening Solutions Now Shipping with UNIFI 1.6 New Software for Research & Scientific Thermal Imagers Thermo Fisher Scientific Introduces Data System to Unite Chromatography and Mass Spectrometry Molecular Devices Introduces SoftMax Pro 6 GxP Microplate Data Acquisition and Analysis Software Short Guide to 3D Cell Culture New EFS Handbook Published by Lee Products The Perfect Ultrafiltration Device for Your Specific Need Electron Magnetic Resonance shrinks to fit the undergraduate curriculum Biotage Releases New Catalog and Technical Guide for Sample Preparation and Evaporation New Waters Quality Parts, Chromatography Columns and Supplies Catalog
|
Argenta expands collaboration with Genentech to include BioFocus
publication date: Sep 14, 2010
|
author/source: Alto Marketing Limited
Argenta, a service division of Galapagos NV (Euronext: GLPG), announced today it has signed a contract extension with Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY). The extended agreement expands the portfolio of projects which are in collaboration with Genentech and allows Genentech to place projects directly into Galapagos' other service division, BioFocus. Argenta's collaboration with Genentech dates back to 2005. The current agreement covers a number of drug discovery programs that utilize Argenta's expertise in computer-aided drug design (CADD), medicinal chemistry, and in vitro biology and screening to discover new chemical entities acting against undisclosed drug targets defined by Genentech. Under the amendment announced today, BioFocus will provide Genentech with integrated medicinal chemistry, in vitro biology and ADME services. "We are delighted that Genentech has expanded its small-molecule drug discovery outsourcing into BioFocus, and we regard it as testament to the complementary expertise and technological capabilities that Argenta and BioFocus possess," said Chris Newton, Senior Vice President, Galapagos Services. About BioFocus BioFocus aims to expand its partners' drug pipelines by accelerating the gene-to-drug candidate discovery process. This is achieved through a comprehensive discovery platform, which includes target discovery in human primary cells, focused as well as diverse compound libraries, in vitro and cell-based screening, structural biology, medicinal chemistry, ADME/PK services, supported by unique chemogenomic and informatics tools, and compound library acquisition, storage and distribution services. As a service division of Galapagos, BioFocus has over 250 employees in four countries worldwide. More info at: www.biofocus.com About Argenta Argenta's contract research, which includes expertise in medicinal chemistry, computer-aided drug discovery, in vitro biology, analytics, in vivo pharmacokinetics, pharmacology and world-leading respiratory models, has a strong reputation for scientific excellence. Argenta was acquired by Galapagos in February 2010 and employs over 140 people in the UK with its main operations in Harlow. More info at: www.argentadiscovery.com BioFocus® is a trademarks of Galapagos NV and/or its affiliates © Copyright 2010 Galapagos NV. |
|
